A systematic overview of published antimalarial drug trials.

A systematic overview of published antimalarial drug trials.

Systematic database searches identified 435 antimalarial drug treatment trials, involving 82,616 patients, conducted and published between 1966 and December 2002. Of these trials 72% were randomised; 64 (15%) trials involved severe malaria, 47 (11%) studied Plasmodium vivax, 3 Plasmodium malariae or...

Bibliografski detalji
Glavni autori:	Myint, H, Tipmanee, P, Nosten, F, Day, N, Pukrittayakamee, S, Looareesuwan, S, White, N
Format:	Journal article
Jezik:	English
Izdano:	2004

Slični predmeti

Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria.
od: Pukrittayakamee, S, i dr.
Izdano: (2004)

Therapeutic responses to different antimalarial drugs in vivax malaria.
od: Pukrittayakamee, S, i dr.
Izdano: (2000)

Mode of action and features of antimalarial drugs
od: Nosten, F, i dr.
Izdano: (1999)

Mode of action and features of antimalarial drugs.
od: Nosten, F, i dr.
Izdano: (1999)

In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand.
od: Chotivanich, K, i dr.
Izdano: (2004)

Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria.
od: Pukrittayakamee, S, i dr.
Izdano: (2008)

Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs
od: Chairat, K, i dr.
Izdano: (2018)

The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy.
od: Mcgready, R, i dr.
Izdano: (2002)

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
od: van Vugt, M, i dr.
Izdano: (1999)

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.
od: Phyo, A, i dr.
Izdano: (2016)

Abnormal circulatory control in falciparum malaria: the effects of antimalarial drugs.
od: Supanaranond, W, i dr.
Izdano: (1993)

Hypoglycaemia and antimalarial drugs: quinidine and release of insulin.
od: Phillips, R, i dr.
Izdano: (1986)

Antimalarial drug resistance
od: White, N
Izdano: (2004)

Antimalarial drug resistance.
od: White, N
Izdano: (2004)

Cardiotoxicity of antimalarial drugs.
od: White, N
Izdano: (2007)

Antimalarial drugs reduce cytoadherence and rosetting Plasmodium falciparum.
od: Udomsangpetch, R, i dr.
Izdano: (1996)

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
od: Price, R, i dr.
Izdano: (2007)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
od: Price, R, i dr.
Izdano: (2007)

The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol).
od: van Vugt, M, i dr.
Izdano: (1998)

The assessment of antimalarial drug efficacy.
od: White, N
Izdano: (2002)

Clinical pharmacokinetics of antimalarial drugs.
od: White, N
Izdano: (1985)

The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria.
od: Chotivanich, K, i dr.
Izdano: (2000)

Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum.
od: Mcgready, R, i dr.
Izdano: (2001)

Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine.
od: Brockman, A, i dr.
Izdano: (2000)

Parasitological efficacy of antimalarials in the treatment and prevention of falciparum malaria in pregnancy 1998 to 2009: a systematic review.
od: Mcgready, R, i dr.
Izdano: (2011)

The threat of antimalarial drug resistance
od: Hanboonkunupakarn, B, i dr.
Izdano: (2016)

Artemisinin antimalarials in pregnancy: A prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum
od: McGready, R, i dr.
Izdano: (2001)

Antimalarial drug resistance: the pace quickens.
od: White, N
Izdano: (1992)

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
od: Barnes, K, i dr.
Izdano: (2005)

Antimalarial drug toxicity: a review.
od: Taylor, W, i dr.
Izdano: (2004)

Antimalarial effects of rifampin in Plasmodium vivax malaria.
od: Pukrittayakamee, S, i dr.
Izdano: (1994)

Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria.
od: Stepniewska, K, i dr.
Izdano: (2006)

An overview of pharmacokinetics of antimalarial drugs in the treatment of pregnant women with uncomplicated malaria
od: Lindegardh, N
Izdano: (2011)

A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults
od: Hanboonkunupakarn, B, i dr.
Izdano: (2024)

The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review
od: Haeusler, I, i dr.
Izdano: (2018)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
od: Olliaro Piero, i dr.
Izdano: (2007-09-01)

Delaying antimalarial drug resistance with combination chemotherapy.
od: White, N
Izdano: (1999)

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.
od: White, N
Izdano: (1997)

Preventing antimalarial drug resistance through combinations.
od: White, N
Izdano: (1998)

Antimalarial drugs in pregnancy: a review.
od: Nosten, F, i dr.
Izdano: (2006)